353 related articles for article (PubMed ID: 12006382)
1. Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis.
Barbier O; Torra IP; Duguay Y; Blanquart C; Fruchart JC; Glineur C; Staels B
Arterioscler Thromb Vasc Biol; 2002 May; 22(5):717-26. PubMed ID: 12006382
[TBL] [Abstract][Full Text] [Related]
2. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
Chinetti G; Fruchart JC; Staels B
Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
[TBL] [Abstract][Full Text] [Related]
3. PPARS in inflammation, atherosclerosis and thrombosis.
Duez H; Fruchart JC; Staels B
J Cardiovasc Risk; 2001 Aug; 8(4):187-94. PubMed ID: 11550996
[TBL] [Abstract][Full Text] [Related]
4. The peroxisome proliferator-activated receptor beta/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells.
Dressel U; Allen TL; Pippal JB; Rohde PR; Lau P; Muscat GE
Mol Endocrinol; 2003 Dec; 17(12):2477-93. PubMed ID: 14525954
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferator-activated receptors and atherogenesis: regulators of gene expression in vascular cells.
Marx N; Duez H; Fruchart JC; Staels B
Circ Res; 2004 May; 94(9):1168-78. PubMed ID: 15142970
[TBL] [Abstract][Full Text] [Related]
6. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
Bocher V; Chinetti G; Fruchart JC; Staels B
J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
[TBL] [Abstract][Full Text] [Related]
7. Regulation of lipid and lipoprotein metabolism by PPAR activators.
Gervois P; Torra IP; Fruchart JC; Staels B
Clin Chem Lab Med; 2000 Jan; 38(1):3-11. PubMed ID: 10774955
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptors in inflammation control.
Delerive P; Fruchart JC; Staels B
J Endocrinol; 2001 Jun; 169(3):453-9. PubMed ID: 11375115
[TBL] [Abstract][Full Text] [Related]
9. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation.
Schoonjans K; Staels B; Auwerx J
Biochim Biophys Acta; 1996 Jul; 1302(2):93-109. PubMed ID: 8695669
[TBL] [Abstract][Full Text] [Related]
10. PPARs: transcription factors controlling lipid and lipoprotein metabolism.
Bocher V; Pineda-Torra I; Fruchart JC; Staels B
Ann N Y Acad Sci; 2002 Jun; 967():7-18. PubMed ID: 12079830
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptors: from transcriptional control to clinical practice.
Torra IP; Chinetti G; Duval C; Fruchart JC; Staels B
Curr Opin Lipidol; 2001 Jun; 12(3):245-54. PubMed ID: 11353326
[TBL] [Abstract][Full Text] [Related]
12. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors with functions in the vascular wall.
Chinetti G; Fruchart JC; Staels B
Z Kardiol; 2001; 90 Suppl 3():125-32. PubMed ID: 11374025
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor-alpha activators regulate genes governing lipoprotein metabolism, vascular inflammation and atherosclerosis.
Fruchart JC; Duriez P; Staels B
Curr Opin Lipidol; 1999 Jun; 10(3):245-57. PubMed ID: 10431661
[TBL] [Abstract][Full Text] [Related]
14. Differential inhibition of macrophage foam-cell formation and atherosclerosis in mice by PPARalpha, beta/delta, and gamma.
Li AC; Binder CJ; Gutierrez A; Brown KK; Plotkin CR; Pattison JW; Valledor AF; Davis RA; Willson TM; Witztum JL; Palinski W; Glass CK
J Clin Invest; 2004 Dec; 114(11):1564-76. PubMed ID: 15578089
[TBL] [Abstract][Full Text] [Related]
15. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression.
Schoonjans K; Staels B; Auwerx J
J Lipid Res; 1996 May; 37(5):907-25. PubMed ID: 8725145
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptors and the control of inflammation.
Cabrero A; Laguna JC; Vázquez M
Curr Drug Targets Inflamm Allergy; 2002 Sep; 1(3):243-8. PubMed ID: 14561188
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease.
Guan Y; Breyer MD
Kidney Int; 2001 Jul; 60(1):14-30. PubMed ID: 11422732
[TBL] [Abstract][Full Text] [Related]
18. Differential regulation of macrophage peroxisome proliferator-activated receptor expression by glucose : role of peroxisome proliferator-activated receptors in lipoprotein lipase gene expression.
Sartippour MR; Renier G
Arterioscler Thromb Vasc Biol; 2000 Jan; 20(1):104-10. PubMed ID: 10634806
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptors: from genes to physiology.
Kliewer SA; Xu HE; Lambert MH; Willson TM
Recent Prog Horm Res; 2001; 56():239-63. PubMed ID: 11237216
[TBL] [Abstract][Full Text] [Related]
20. [PPARs: physiological functions and pharmacological roles of agonists in human diseases. Note II].
Filip-Ciubotaru F; Manciuc C; Grigore C; Foia L
Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):240-7. PubMed ID: 23077903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
